Full Name
Brandon Kitay MD, PhD
Job Title
Assistant Prof./Dir. BH Integration
Company
Emory School of Medicine
City (Address)
Atlanta
State/Province/County (Address)
GA
Speaker Short Bio
Brandon Kitay, MD, PhD is an Assistant Professor of Psychiatry and Behavioral Sciences and the Director of Behavioral Health Integration for Emory Healthcare. In 2020, Emory Healthcare established the Integrated Behavioral Health (IBH) Program as a commitment to improving access and quality of behavioral health services across the enterprise. Since 2021, the Program’s efforts have included implementation of the Collaborative Care Model (CoCM) serving a population of over 37,000 primary care patients at four sites and promoting efforts to scale expertise through promoting measurement-based care and interprofessional “e-Consultation.” The IBH Program is also leading innovation through application of integrated care services in novel specialty populations, leveraging digital mental health technologies (DMHTs) to benefit scalability and sustainability.
Dr. Kitay is a graduate of the University of Miami School of Medicine MD/PhD Program, completed residency at the Yale University School of Medicine in Adult Psychiatry through the Neuroscience Research Training Program (NRTP), and fellowship/research training in Interventional Psychiatry at the Yale Depression Research Program. In addition to his academic and health system administration roles, his research involves the application of health service models to improve access and quality of mental healthcare as well as the conduct of clinical trials involving novel therapeutics for treatment refractory psychiatric conditions. He is a clinical expert in the management of "treatment refractory depression" including the delivery and application of electroconvulsive therapy (ECT) and ketamine/esketamine therapy.
Dr. Kitay is a graduate of the University of Miami School of Medicine MD/PhD Program, completed residency at the Yale University School of Medicine in Adult Psychiatry through the Neuroscience Research Training Program (NRTP), and fellowship/research training in Interventional Psychiatry at the Yale Depression Research Program. In addition to his academic and health system administration roles, his research involves the application of health service models to improve access and quality of mental healthcare as well as the conduct of clinical trials involving novel therapeutics for treatment refractory psychiatric conditions. He is a clinical expert in the management of "treatment refractory depression" including the delivery and application of electroconvulsive therapy (ECT) and ketamine/esketamine therapy.
Speaking At
